125 related articles for article (PubMed ID: 38856147)
41. MicroRNA-28-5p regulates glioma cell proliferation, invasion and migration by targeting SphK1.
Chen HS; Lu AQ; Yang PY; Liang J; Wei Y; Shang YW; Li Q
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10302. PubMed ID: 33155264
[TBL] [Abstract][Full Text] [Related]
42. LINC00346 accelerates the malignant progression of colorectal cancer via competitively binding to miRNA-101-5p/MMP9.
Tong WH; Mu JF; Zhang SP
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3398. PubMed ID: 34002807
[TBL] [Abstract][Full Text] [Related]
43. MiRNA-146b-5p inhibits the malignant progression of gastric cancer by targeting TRAF6.
Ding JN; Zang YF; Ding YL
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3151. PubMed ID: 33928598
[TBL] [Abstract][Full Text] [Related]
44. MiR-210 suppresses neuronal apoptosis in rats with cerebral infarction through regulating VEGF-notch signaling pathway.
Jiang YL; Liu WW; Wang Y; Yang WY
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):2. PubMed ID: 33506881
[TBL] [Abstract][Full Text] [Related]
45. MiR-182-5p inhibited proliferation and migration of ovarian cancer cells by targeting BNIP3.
Jia XN; Yin SD; Wei Y; Chen L
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7912. PubMed ID: 32767306
[TBL] [Abstract][Full Text] [Related]
46. LncRNA PAPAS aggravates the progression of gastric cancer through regulating miRNA-188-5p.
Shi X; You X; Zeng WC; Deng YJ; Hong HL; Huang OX; Wang MF
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2462. PubMed ID: 33829425
[TBL] [Abstract][Full Text] [Related]
47. MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2.
Shi XY; Wang H; Wang W; Gu YH
Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10914. PubMed ID: 33215398
[TBL] [Abstract][Full Text] [Related]
48. Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells.
Wang H; Xu T; Wu L; Xu HL; Liu RM
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6159. PubMed ID: 34730189
[TBL] [Abstract][Full Text] [Related]
49. Retraction Note: Overexpression of long non-coding RNA TUG1 alleviates TNF-α-induced inflammatory injury in interstitial cells of Cajal.
Zhao K; Tan JY; Mao QD; Ren KY; He BG; Zhang CP; Wei LZ
Eur Rev Med Pharmacol Sci; 2023 Jul; 27(13):5946. PubMed ID: 37458619
[TBL] [Abstract][Full Text] [Related]
50. MicroRNA-191-5p promotes the development of osteosarcoma via targeting EGR1 and activating the PI3K/AKT signaling pathway.
Chen B; Zheng ZY; Yang JZ; Li XG
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3145. PubMed ID: 33928592
[TBL] [Abstract][Full Text] [Related]
51. MiR-524 inhibits cell proliferation and induces cell apoptosis in thyroid cancer via targeting SPAG9.
Zhen Z; Dong F; Shen H; Wang QG; Yang L; Hu J
Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7192. PubMed ID: 34919215
[TBL] [Abstract][Full Text] [Related]
52. MiR-466 as a poor prognostic predictor suppresses cell proliferation and EMT in breast cancer cells by targeting PSMA7.
Xiao Y; Zhang SJ; Yan X; Wu C; Liu QW; Dong HX; Wang LJ; Hu Y
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3799. PubMed ID: 35731048
[TBL] [Abstract][Full Text] [Related]
53. Mechanism of LncRNA ROR promoting prostate cancer by regulating Akt.
Zhai XQ; Meng FM; Hu SF; Sun P; Xu W
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(5):2155. PubMed ID: 33755944
[TBL] [Abstract][Full Text] [Related]
54. MiR-195 inhibits myocardial fibrosis in hypertensive rats by regulating TGFβ1-Smad3 signaling pathway.
Xu Q; Lin XX; Liu P; Zhang W; Tang K; Zhai YS; Liu LJ; Mei WY
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):7919. PubMed ID: 32767312
[TBL] [Abstract][Full Text] [Related]
55. Circ0021205 aggravates the progression of non-small cell lung cancer by targeting miRNA-16-5p/VEGFA.
Yang Y; Huang XJ
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3148. PubMed ID: 33928595
[TBL] [Abstract][Full Text] [Related]
56. Circ_0005276 aggravates the development of epithelial ovarian cancer by targeting ADAM9.
Liu ZH; Liu WJ; Yu XY; Qi XL; Sun CC
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3798. PubMed ID: 35731047
[TBL] [Abstract][Full Text] [Related]
57. MiR-155-5p affects Wilms' tumor cell proliferation and apoptosis via targeting CREB1.
Zhao XS; Han B; Zhao JX; Tao N; Dong CY
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):6826. PubMed ID: 34859841
[TBL] [Abstract][Full Text] [Related]
58. Retraction Note: Randomized, double blind placebo-controlled trial: effects of Myo-inositol on ovarian function and metabolic factors in women with PCOS.
Gerli S; Papaleo E; Ferrari A; Di Renzo GC
Eur Rev Med Pharmacol Sci; 2023 Sep; 27(18):8323. PubMed ID: 37782148
[TBL] [Abstract][Full Text] [Related]
59. Long non-coding RNA TTN-AS1 promotes the metastasis in breast cancer by epigenetically activating DGCR8.
Qiu P; Dou Y; Ma LZ; Tang XX; Liu XL; Chen JW
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7559. PubMed ID: 32744664
[TBL] [Abstract][Full Text] [Related]
60. RETRACTED: Physcion 8-O-β-glucopyranoside inhibits clear-cell renal cell carcinoma bydownregulating hexokinase II and inhibiting glycolysis.
Wang Q; Yan Y; Zhang J; Guo P; Xing Y; Wang Y; Qin F; Zeng Q
Biomed Pharmacother; 2018 Aug; 104():28-35. PubMed ID: 29758413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
